UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Update of testis cancer guidelines

European urology supplements : official journal of the European Association of Urology, 2016, Vol.15 (2), p.54-54a

Jabłonowski, Z

2016

Volltextzugriff (PDF)

The utility of non-coding RNA UCA1 as a urinary marker for bladder cancer

European urology open science (Online), 2022-06, Vol.40, p.S30

2022

Volltextzugriff (PDF)

MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer

Clinical biochemistry, 2015-12, Vol.48 (18), p.1235-1240

2015

Volltextzugriff (PDF)

Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis

Neoplasma, 2016, Vol.63 (6), p.952-960

2016

Volltextzugriff (PDF)

C113: Quality of life in the population of Polish patients with prostate cancer

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (6), p.e1299-e1299

2014

Volltextzugriff (PDF)

C120 Photodynamic diagnosis of bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis

European urology supplements : official journal of the European Association of Urology, 2013-10, Vol.12 (4), p.e1228, C120-e1228, C120

2013

Volltextzugriff (PDF)

Expression of NRF2 and NRF2-modulated genes in peripheral blood leukocytes of bladder cancer males

Neoplasma, 2013-01, Vol.60 (2), p.123-128

2013

Volltextzugriff (PDF)

C207: Detection of bladder cancer in urine by a methylation panel of selected tumour suppressor genes

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (6), p.e1375-e1375

2014

Volltextzugriff (PDF)

C209: The significance of Ala179Thr polymorphism in WWOX gene in the bladder cancer development

European urology supplements : official journal of the European Association of Urology, 2014-11, Vol.13 (6), p.e1377-e1377

2014

Volltextzugriff (PDF)

C110 Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation assay using tumor and urine sediment DNA

European urology supplements : official journal of the European Association of Urology, 2013-10, Vol.12 (4), p.e1218, C110-e1218, C110

2013

Volltextzugriff (PDF)

PMD92 - Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland

Value in health, 2015-11, Vol.18 (7), p.A360-A360

2015

Volltextzugriff (PDF)

Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland

Value in health, 2015-11, Vol.18 (7), p.A360-A360

2015

Volltextzugriff (PDF)

Frequency of contact with ticks and pathogenic effects of such contacts in forestry workers of north-eastern Poland

International journal of medical microbiology, 2002-06, Vol.291, p.214-214

2002

Volltextzugriff (PDF)

101 - No gender diversities in outcomes in patients diagnosed with non-muscle invasive, highrisk bladder cancer treated with early second resection and BCG – a multicenter analysis

European urology supplements : official journal of the European Association of Urology, 2019-05, Vol.18 (2), p.e2409-e2409

2019

Volltextzugriff (PDF)

No gender diversities in outcomes in patients diagnosed with non-muscle invasive, highrisk bladder cancer treated with early second resection and BCG – a multicenter analysis

European urology supplements : official journal of the European Association of Urology, 2019-05, Vol.18 (2), p.e2409

2019

Volltextzugriff (PDF)

535 Validation of EORTC QLQ-C30 and QLQ-PR25 questionnaires for quality of life assessment among Polish prostate cancer patients

European urology supplements : official journal of the European Association of Urology, 2014-04, Vol.13 (1), p.e535-e535

2014

Volltextzugriff (PDF)

75 - Pyuria can be prognostic marker for poor oncological outcome prior TUR-BT

European urology supplements : official journal of the European Association of Urology, 2018-07, Vol.17 (5), p.e2238-e2239

2018

Volltextzugriff (PDF)

Pyuria can be prognostic marker for poor oncological outcome prior TUR-BT

European urology supplements : official journal of the European Association of Urology, 2018-07, Vol.17 (5), p.e2238-e2239

2018

Volltextzugriff (PDF)

71 - Men have an increased incidence of high stage bladder cancer

European urology supplements : official journal of the European Association of Urology, 2018-07, Vol.17 (5), p.e2236-e2236

2018

Volltextzugriff (PDF)

Men have an increased incidence of high stage bladder cancer

European urology supplements : official journal of the European Association of Urology, 2018-07, Vol.17 (5), p.e2236

2018

Volltextzugriff (PDF)

The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial

BJU international, 2002-05, Vol.89 (7), p.771-772

2002

Volltextzugriff (PDF)

Meta-analysis of diagnostic validity and safety of TURBT using hexaminolevulinate for non-muscle invasive bladder cancer (NMIBC)

European urology supplements : official journal of the European Association of Urology, 2015-10, Vol.14 (6), p.e1334-e1334

2015

Volltextzugriff (PDF)

C91 EVALUATING EXPRESION OF TP53, RB, RAS, FGFR3 GENES IN BLADDER CANCER RELATIVE TO MUTATION OCURRENCE AND CLINICOPATHOLOGICAL PARA METERS

European urology supplements : official journal of the European Association of Urology, 2011, Vol.10 (9), p.635-635

2011

Volltextzugriff (PDF)

Influence of the pH of the cultivation medium on survival and development of stage III larvae of Anisakis simplex

Wiadomości parazytologiczne, 2001, Vol.47 (3), p.317

2001

Volltextzugriff (PDF)

Long noncoding RNA linked to the development of bladder cancer

European urology supplements : official journal of the European Association of Urology, 2015-10, Vol.14 (6), p.e1324-e1324

2015

Volltextzugriff (PDF)

1 – 25 von 84

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(84)

Sprache

Englisch
(52)
Polnisch
(32)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Update of testis cancer guidelines

The utility of non-coding RNA UCA1 as a urinary marker for bladder cancer

MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer

Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation analysis

C113: Quality of life in the population of Polish patients with prostate cancer

C120 Photodynamic diagnosis of bladder cancer with hexaminolevulinate cystoscopy: A meta-analysis

Expression of NRF2 and NRF2-modulated genes in peripheral blood leukocytes of bladder cancer males

C207: Detection of bladder cancer in urine by a methylation panel of selected tumour suppressor genes

C209: The significance of Ala179Thr polymorphism in WWOX gene in the bladder cancer development

C110 Genetic diversity of urinary bladder cancer and the risk of recurrence based on mutation assay using tumor and urine sediment DNA

PMD92 - Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland

Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc) In Poland

Frequency of contact with ticks and pathogenic effects of such contacts in forestry workers of north-eastern Poland

101 - No gender diversities in outcomes in patients diagnosed with non-muscle invasive, highrisk bladder cancer treated with early second resection and BCG – a multicenter analysis

No gender diversities in outcomes in patients diagnosed with non-muscle invasive, highrisk bladder cancer treated with early second resection and BCG – a multicenter analysis

535 Validation of EORTC QLQ-C30 and QLQ-PR25 questionnaires for quality of life assessment among Polish prostate cancer patients

75 - Pyuria can be prognostic marker for poor oncological outcome prior TUR-BT

Pyuria can be prognostic marker for poor oncological outcome prior TUR-BT

71 - Men have an increased incidence of high stage bladder cancer

Men have an increased incidence of high stage bladder cancer

The efficacy of terazosin for treating benign prostatic hyperplasia: a multicentre clinical trial

Meta-analysis of diagnostic validity and safety of TURBT using hexaminolevulinate for non-muscle invasive bladder cancer (NMIBC)

C91 EVALUATING EXPRESION OF TP53, RB, RAS, FGFR3 GENES IN BLADDER CANCER RELATIVE TO MUTATION OCURRENCE AND CLINICOPATHOLOGICAL PARA METERS

Influence of the pH of the cultivation medium on survival and development of stage III larvae of Anisakis simplex

Long noncoding RNA linked to the development of bladder cancer

Suchergebnisse filtern